Comparison

ReproAnswer vs PubMed Summaries

Price, ratings, monetisation and update history for both apps, side by side β€” with what reviewers say about each.

Head to head
About

ReproAnswer

Features
Read full description

Integrating authoritative information from multiple gold-standard sources, ReproAnswerβ„’ supports health care providers as they assess medication risk with pregnant patients. Use ReproAnswer to: β€’ FIND authoritative information to support medication safety in pregnancy and lactation β€’ UNDERSTAND quickly by efficiently searching for and returning topic-specific information β€’ DECIDE on appropriate medication treatment options for pregnancy and lactation β€’ EXPLAIN to patients and family members so they feel more comfortable with the decision Why ReproAnswer? For most medications: β€’ the safety or risk profile is either unknown or very difficult to find β€’ it is difficult for healthcare providers and pregnant women to weigh the risks and benefits of treatment options According to the Centers for Disease Control and Prevention (CDC): β€’ Every infant has at least a 5% risk of being born with a serious congenital anomaly β€’ 9 of 10 women take at least one medication during pregnancy β€’ Medication use in pregnancy up more than 60% in last 30 years β€’ Women struggle with decisions regarding medication use in pregnancy β€’ Pregnant patients may discontinue or underuse needed medications due to fear β€’ Without treatment, the woman and/or her baby could be harmed

About

PubMed Summaries

Features
Read full description

PaperRounds uses AI to turn PubMed papers into structured summaries for medical students, residents, clinicians and researchers β€” and every line points to the sentence in the paper it comes from. WHAT'S INSIDE β€’ Every paper in five minutes Population, intervention, outcome, findings and harms β€” each backed by a sentence from the abstract. Deep summaries read the open full text. β€’ Ask the literature Ask a question: PubMed is searched, up to 30 abstracts read, every sentence with its source. Or request a report from up to 80. β€’ See what the numbers support Evidence Check shows design, sample, follow-up and what to watch for β€” on your phone, free. Flashcards help you remember each paper. β€’ Journal club, ready Slides with speaker notes and a one-page handout from any summary. Line up 2–4 papers side by side. β€’ Never miss what changed Every Monday, new trials, meta-analyses and guidelines from your journals. For each paper: which guidelines cited it, and whether it was retracted. β€’ Get past the paywall, legally Finds legal free copies of a paper β€” PMC, Europe PMC, repositories β€” and can summarize the open full text. β€’ In your language Every summary, answer and report written in your language β€” drug names, numbers and PMIDs kept exact. 30 languages. β€’ Connect Zotero Papers you summarize go to your Zotero library with the summary attached. Connect in Settings. β€’ On iPhone, iPad and iPhone Duo Connect with Apple and your library and topics stay in step across your iPhone and iPad. On iPhone Duo, the unfolded screen gets the wide iPad layout. PAPERROUNDS PRO β€’ 50 summaries a day, 10 from the full text Deep summaries read the open full text; every field cites the paper. β€’ Ask the literature Ask a question: 30 PubMed abstracts read, every sentence cited. 30 a day. β€’ Deep literature report From 80 abstracts: a study table, disagreements and gaps, as a PDF. 3 a day. β€’ Side by side, and journal club Compare 2–4 papers in a table. Slides, speaker notes and a one-page handout. β€’ After publication The full lists of guidelines, meta-analyses and RCTs that cited a paper. β€’ In your language Summaries, answers and reports in 30 languages β€” drug names, numbers and PMIDs kept exact. Without Pro: Evidence Check, the weekly digest, finding legal free full texts, and one summary to try. RESEARCH AND EDUCATION ONLY PaperRounds helps summarize published medical literature for learning and research. It is not a medical device and does not provide diagnosis or treatment recommendations. Always verify summaries against the original article and your clinical judgment. β€”β€”β€”β€”β€”β€”β€” Support: https://www.notion.so/Support-PaperRounds-3660cc7ee73680b5b00cf8327cc176bb?source=copy_link Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Privacy Policy: https://www.notion.so/Privacy-Policy-PaperRounds-3660cc7ee736801a87dcc66cdf6e1c19?source=copy_link

Screenshots

ReproAnswer4 screens
PubMed Summaries4 screens

Verdict

The call

The clearest difference is in-app purchases: ReproAnswer at none against PubMed Summaries's 3. ReproAnswer also leads on iOS requirement (14.0 vs 18.0). On price, ads and device support there is nothing between them.

Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS

CostPrice Β· In-app purchases Β· Ads Β· Monetization

Both are free to download. PubMed Summaries sells 3 in-app purchases, starting at $4.99 per 7 days. ReproAnswer asks for nothing beyond the download.

Scorecard2 real differences Β· 4 level
ReproAnswer versus PubMed Summaries: the parameters behind the verdict, then further details
ParameterReproAnswerPubMed Summaries
PriceFreeFree
Update frequencyβ€”Every 5 months
AdsNoNo
In-app purchasesNo β€” betterYes
DevicesiPhone, iPad, iPod β€” betteriPhone, iPad
Requires iOS14.0 β€” better18.0
Further details β€” not scored
Size13 MB121 MB
Age rating17+4+
DeveloperRightAnswer.com, Inc.MUHAMMET USLU

In-app purchases

None

ReproAnswer

No in-app purchases

3 purchases

PubMed Summaries

Subscriptions2
  • Weekly Pro3 Days trial$4.997 Days
  • Yearly Pro$99.991 Year
One-time1
  • Disposable Production$0.99

Questions

Is ReproAnswer free?
ReproAnswer is free to download, with no in-app purchases.
Is PubMed Summaries free?
PubMed Summaries is free to download, with in-app purchases available.
Do ReproAnswer or PubMed Summaries have ads?
Neither ReproAnswer nor PubMed Summaries shows ads.

Other comparisons